trending Market Intelligence /marketintelligence/en/news-insights/trending/b3bzr1squmqihutg5ac1pw2 content esgSubNav
In This List

Novo Nordisk adds board members

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Novo Nordisk adds board members

Bagsvaerd, Denmark-based Novo Nordisk A/S' board of directors proposed the election of Andreas Fibig and Martin Mackay as board members.

Fibig is the CEO and chairman of International Flavors & Fragrances Inc., while Mackay was formerly the executive vice president and global head of research and development at Alexion Pharmaceuticals Inc.

Both appointments will be proposed at the drugmaker's annual meeting in March.